- Development of nested PCR technology for accurate tick fever screening.
- Offering diagnostics in molecular biology, microbiology, pathology, and more.
- Expanding into B2B and B2G markets, ensuring broad service reach.
New Delhi, 30-06-2024 – VETDIAG GENOMIX PRIVATE LIMITED has been awarded the Best HealthTech Solution Provider at Startup Mahakumbh 2024, recognizing its pioneering work in veterinary diagnostics.
VETDIAG GENOMIX specializes in providing comprehensive veterinary services encompassing molecular biology, microbiology, pathology, biochemistry, and hematology. Their groundbreaking work includes the development of patented nested PCR technology specifically designed for screening tick fever panels, setting a new standard in veterinary diagnostics.
The company’s approach integrates state-of-the-art PCR and RT-PCR machines, ensuring accurate and reliable results by isolating pathogen DNA. This technological advancement not only enhances diagnostic precision but also contributes significantly to the early detection and management of animal diseases.
With a strategic focus on both business-to-business (B2B) and business-to-government (B2G) markets, VETDIAG GENOMIX aims to broaden its impact and reach within the veterinary healthcare sector. By offering cutting-edge diagnostic capabilities, they empower veterinarians, livestock owners, and agricultural stakeholders with critical insights for informed decision-making and proactive health management.
Startup Mahakumbh is renowned for celebrating innovation and entrepreneurship across various domains. VETDIAG GENOMIX’s recognition as the Best HealthTech Solution Provider underscores their commitment to leveraging technology to improve animal health outcomes and advance the veterinary care landscape.
About Startup Mahakumbh
Startup Mahakumbh is a premier platform that honors outstanding achievements in the startup ecosystem, bringing together visionaries, investors, and industry leaders to celebrate innovation and excellence.
